Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 32
Filtrar
Mais filtros








Intervalo de ano de publicação
1.
Arch Microbiol ; 205(7): 258, 2023 Jun 08.
Artigo em Inglês | MEDLINE | ID: mdl-37286902

RESUMO

Probiotic microorganisms are increasing their interest today due to the benefits they provide to humans. Vinegar is the process of processing foods containing carbohydrates that can be fermented by acetic acid bacteria and yeasts. Hawthorn vinegar is also important in terms of amino acids, aromatic compounds, organic acids, vitamins and minerals it contains. Depending on the variety of microorganisms in it, the content of hawthorn vinegar changes, especially its biological activity. Bacteria were isolated from handmade hawthorn vinegar obtained in this study. After performing its genotypic characterization, it has been tested that it can grow in low pH environment, survive in artificial gastric and small intestinal fluid, survive against bile acids, surface adhesion characteristics, antibiotic susceptibility, adhesion, and degrade various cholesterol precursors. According to the results obtained, the studied isolate is Levilactobacillus brevis, it can reproduce best at pH 6.3, survives 72.22% in simulated gastric juice, 69.59% in small intestinal fluid, and 97% adhesion to HTC-116. Partially reproduces even in the presence of 2% ox-bile, surface hydrophobicity is 46.29% for n-hexadecane. It has been determined that it can degrade 4 different cholesterol precursors except for Sodium thioglycolate and is generally resistant to antibiotics except for CN30 and N30. Considering the experimental findings of Levilactobacillus brevis isolated from hawthorn vinegar for the first time, it can be said that Levilactobacillus brevis has probiotic properties.


Assuntos
Ácido Acético , Levilactobacillus brevis , Probióticos , Humanos , Crataegus/microbiologia , Suco Gástrico/microbiologia , Levilactobacillus brevis/efeitos dos fármacos , Levilactobacillus brevis/genética , Levilactobacillus brevis/isolamento & purificação , Levilactobacillus brevis/metabolismo , Probióticos/isolamento & purificação , Probióticos/metabolismo , Microbiologia de Alimentos , Células HCT116 , Aderência Bacteriana , Antibacterianos/farmacologia , RNA Ribossômico 16S/genética , Concentração de Íons de Hidrogênio , Ácidos e Sais Biliares/farmacologia , Interações Hidrofóbicas e Hidrofílicas
2.
Development ; 148(5)2021 03 09.
Artigo em Inglês | MEDLINE | ID: mdl-33593820

RESUMO

Microbial factors influence homeostatic and oncogenic growth in the intestinal epithelium. However, we know little about immediate effects of commensal bacteria on stem cell division programs. In this study, we examined the effects of commensal Lactobacillus species on homeostatic and tumorigenic stem cell proliferation in the female Drosophila intestine. We identified Lactobacillus brevis as a potent stimulator of stem cell divisions. In a wild-type midgut, L.brevis activates growth regulatory pathways that drive stem cell divisions. In a Notch-deficient background, L.brevis-mediated proliferation causes rapid expansion of mutant progenitors, leading to accumulation of large, multi-layered tumors throughout the midgut. Mechanistically, we showed that L.brevis disrupts expression and subcellular distribution of progenitor cell integrins, supporting symmetric divisions that expand intestinal stem cell populations. Collectively, our data emphasize the impact of commensal microbes on division and maintenance of the intestinal progenitor compartment.


Assuntos
Adesão Celular , Proliferação de Células , Drosophila/metabolismo , Intestinos/citologia , Levilactobacillus brevis/fisiologia , Células-Tronco/metabolismo , Animais , Animais Geneticamente Modificados/metabolismo , Antibacterianos/farmacologia , Diferenciação Celular , Linhagem da Célula , Transformação Celular Neoplásica/efeitos dos fármacos , Regulação para Baixo , Drosophila/microbiologia , Proteínas de Drosophila/deficiência , Proteínas de Drosophila/genética , Proteínas de Drosophila/metabolismo , Integrinas/metabolismo , Intestinos/microbiologia , Levilactobacillus brevis/efeitos dos fármacos , Receptores Notch/deficiência , Receptores Notch/genética , Células-Tronco/citologia , Células-Tronco/microbiologia
3.
Nutrients ; 12(4)2020 Apr 21.
Artigo em Inglês | MEDLINE | ID: mdl-32326187

RESUMO

The impact of acrylamide (AA) on microorganisms is still not clearly understood as AA has not induced mutations in bacteria, but its epoxide analog has been reported to be mutagenic in Salmonella strains. The aim of the study was to evaluate whether AA could influence the growth and viability of beneficial intestinal bacteria. The impact of AA at concentrations of 0-100 µg/mL on lactic acid bacteria (LAB) was examined. Bacterial growth was evaluated by the culture method, while the percentage of alive, injured, and dead bacteria was assessed by flow cytometry after 24 h and 48 h of incubation. We demonstrated that acrylamide could influence the viability of the LAB, but its impact depended on both the AA concentration and the bacterial species. The viability of probiotic strain Lactobacillus acidophilus LA-5 increased while that of Lactobacillus plantarum decreased; Lactobacillus brevis was less sensitive. Moreover, AA influenced the morphology of L. plantarum, probably by blocking cell separation during division. We concluded that acrylamide present in food could modulate the viability of LAB and, therefore, could influence their activity in food products or, after colonization, in the human intestine.


Assuntos
Acrilamida/efeitos adversos , Acrilamida/toxicidade , Microbioma Gastrointestinal/efeitos dos fármacos , Lactobacillus acidophilus/efeitos dos fármacos , Lactobacillus plantarum/efeitos dos fármacos , Levilactobacillus brevis/efeitos dos fármacos , Acrilamida/análise , Análise de Alimentos , Manipulação de Alimentos , Produtos Finais de Glicação Avançada , Humanos , Lactobacillus acidophilus/crescimento & desenvolvimento , Levilactobacillus brevis/crescimento & desenvolvimento , Lactobacillus plantarum/crescimento & desenvolvimento
4.
Probiotics Antimicrob Proteins ; 12(4): 1542-1554, 2020 12.
Artigo em Inglês | MEDLINE | ID: mdl-32279232

RESUMO

Functional foods and nutraceuticals frequently contain viable probiotic strains that, at certain titers, are considered to be responsible of beneficial effects on health. Recently, it was observed that secreted metabolites might play a key role in this respect, especially in immunomodulation. Exopolysaccharides produced by probiotics, for example, are used in the food, pharmaceutical, and biomedical fields, due to their unique properties. Lactobacillus brevis CD2 demonstrated the ability to inhibit oral pathogens causing mucositis and periodontal inflammation and to reduce Helycobacter pylori infections. Due to the lack of literature, for this strain, on the development of fermentation processes that can increase the titer of viable cells and associated metabolites to industrially attractive levels, different batch and fed-batch strategies were investigated in the present study. In particular, aeration was shown to improve the growth rate and the yields of lactic acid and biomass in batch cultures. The use of an exponential feeding profile in fed-batch experiments allowed to produce 9.3 ± 0.45 × 109 CFU/mL in 42 h of growth, corresponding to a 20-fold increase of viable cells compared with that obtained in aerated batch processes; moreover, also increased titers of exopolysaccharides and lactic acid (260 and 150%, respectively) were observed. A purification process based on ultrafiltration, charcoal treatment, and solvent precipitation was applied to partially purify secreted metabolites and separate them into two molecular weight fractions (above and below 10 kDa). Both fractions inhibited growth of the known gut pathogen, Salmonella typhimurium, demonstrating that lactic acid plays a major role in pathogen growth inhibition, which is however further enhanced by the presence of Lact. brevis CD2 exopolysaccharides. Finally, the EPS produced from Lact. brevis CD2 was characterized by NMR for the first time up to date.


Assuntos
Meios de Cultura/farmacologia , Ácido Láctico/biossíntese , Levilactobacillus brevis/metabolismo , Polissacarídeos Bacterianos/biossíntese , Probióticos/análise , Técnicas de Cultura Celular por Lotes/métodos , Fracionamento Químico/métodos , Meios de Cultura/química , Suplementos Nutricionais , Fermentação , Alimento Funcional , Humanos , Concentração de Íons de Hidrogênio , Levilactobacillus brevis/efeitos dos fármacos , Peso Molecular , Oxigênio/farmacologia , Polissacarídeos Bacterianos/isolamento & purificação , Polissacarídeos Bacterianos/farmacologia , Salmonella typhimurium/efeitos dos fármacos , Salmonella typhimurium/crescimento & desenvolvimento
5.
Appl Microbiol Biotechnol ; 104(9): 4071-4080, 2020 May.
Artigo em Inglês | MEDLINE | ID: mdl-32179950

RESUMO

This study aimed to model the inactivation of Lactobacillus brevis DSM 6235 while retaining the viability of yeasts during washing brewer's yeast with phosphoric acid and chlorine dioxide. The independent variables in the acid washing were pH (1-3) and temperature (1-9 °C), whereas in the washing with chlorine dioxide, concentration (10-90 mg/L) and temperature (5-25 °C) were assessed. The predictive models obtained for the four response variables γLA, γCl (decimal reduction of L. brevis DSM 6235), Vf/V0LA, and Vf/V0Cl (brewer's yeast viability ratio) were found to have R2 > 0.80 and values of Fcalc > Freference. Then, the models were considered predictive and statistically significant (p < 0.10). Our results indicated that phosphoric acid and chlorine dioxide washing resulted in up to 7 and 6.4 (log CFU/mL) decimal reductions of L. brevis DSM 6235, respectively. On the other hand, the viability of the brewer's yeast ranged from 22.3 to 99.4%. L. brevis DSM 6235 inactivation was significantly influenced by parameters pH(Q) and T°C(Q) when phosphoric acid was applied, and by parameters mg/L(L), mg/L(Q), T°C(Q), and mg/L × T°C when ClO2 was applied. The validation of the models resulted in bias (γLA, 0.93/Vf/V0LA, 0.99 - γCl, 1.0/Vf/V0Cl, 0.99) and accuracy values (γLA, 1.12/Vf/V0LA, 1.01 - γCl, 1.08/Vf/V0Cl, 1.03). The results of this study indicate that it might be possible to decontaminate brewer's yeast through acid and chlorine dioxide washing while keeping its viability. This procedure will result in the reduction of costs and the lower generation of brewer's waste.


Assuntos
Compostos Clorados/farmacologia , Fermentação , Levilactobacillus brevis/fisiologia , Viabilidade Microbiana , Óxidos/farmacologia , Ácidos Fosfóricos/farmacologia , Saccharomyces cerevisiae/fisiologia , Cerveja/microbiologia , Concentração de Íons de Hidrogênio , Levilactobacillus brevis/efeitos dos fármacos , Saccharomyces cerevisiae/efeitos dos fármacos , Temperatura
6.
J Biosci Bioeng ; 128(4): 391-397, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-31126721

RESUMO

We demonstrate here that exopolysaccharide (EPS) production, cell aggregation, and bile resistance in Lactobacillus brevis KB290 are conferred by three eps genes (gtf27, gtf28, and orf29) located on the 42.4-kb plasmid pKB290-1. The predicted products of gtf27 and gtf28 belong to the membrane-bound glycosyltransferase family whereas the orf29 gene product showed homology with the ABC transporter. On in silico analysis, these genes were found to be widely distributed among lactobacilli from publicly available genomes and metagenomes, and their function is not yet elucidated. RT-PCR analysis showed that the eps genes were organised in an operon and their expression was markedly lower in arabinose- and xylose-containing media than in a glucose-containing medium. The three eps genes were cloned and expressed in homologous and heterologous strains. Considerably less EPS was produced by the plasmid-cured KB1802 strain than by the parental KB290 strain, whereas a similar amount was produced by the KB1802 strain expressing the three eps genes. The KB1802 strain expressing gtf27 and gtf28 but not orf29 did not produce EPS. Cell aggregation and bile resistance were also decreased in KB1802 strains but were complemented by eps genes. Moreover, the three eps genes conferred these phenotypes to a Lactobacillus plantarum strain. In conclusion, the three eps genes in pKB290-1 were sufficient for EPS biosynthesis with glucose and N-acetylglucosamine, and were responsible for cell aggregation and bile resistance. We consider these phenotypes to be at least partly responsible for KB290-specific properties.


Assuntos
Glicosiltransferases/metabolismo , Levilactobacillus brevis/enzimologia , Polissacarídeos Bacterianos/biossíntese , Ácidos e Sais Biliares/farmacologia , Glicosiltransferases/genética , Levilactobacillus brevis/efeitos dos fármacos , Levilactobacillus brevis/genética , Lactobacillus plantarum/efeitos dos fármacos , Lactobacillus plantarum/enzimologia , Lactobacillus plantarum/genética , Óperon , Plasmídeos/genética , Probióticos
7.
Microb Cell Fact ; 17(1): 180, 2018 Nov 19.
Artigo em Inglês | MEDLINE | ID: mdl-30454056

RESUMO

BACKGROUND: The glutamate decarboxylase (GAD) system of Lactobacillus brevis involves two isoforms of GAD, GadA and GadB, which catalyze the conversion of L-glutamate to γ-aminobutyric acid (GABA) in a proton-consuming reaction contributing to intracellular pH homeostasis. However, direct experimental evidence for detailed contributions of gad genes to acid tolerance and GABA production is lacking. RESULTS: Molecular analysis revealed that gadB is cotranscribed in tandem with upstream gadC, and that expression of gadCB is greatly upregulated in response to low ambient pH when cells enter the late exponential growth phase. In contrast, gadA is located away from the other gad genes, and its expression was consistently lower and not induced by mild acid treatment. Analysis of deletion mutations in the gad genes of L. brevis demonstrated a decrease in the level of GAD activity and a concomitant decrease in acid resistance in the order of wild-type> ΔgadA> ΔgadB> ΔgadC> ΔgadAB, indicating that the GAD activity mainly endowed by GadB rather than GadA is an indispensable step in the GadCB mediated acid resistance of this organism. Moreover, engineered strains with higher GAD activities were constructed by overexpressing key GAD system genes. With the proposed two-stage pH and temperature control fed-batch fermentation strategy, GABA production by the engineered strain L. brevis 9530: pNZ8148-gadBC continuously increased reaching a high level of 104.38 ± 3.47 g/L at 72 h. CONCLUSIONS: This is the first report of the detailed contribution of gad genes to acid tolerance and GABA production in L. brevis. Enhanced production of GABA by engineered L. brevis was achieved, and the resulting GABA level was one of the highest among lactic acid bacterial species grown in batch or fed-batch culture.


Assuntos
Ácidos/farmacologia , Glutamato Descarboxilase/metabolismo , Levilactobacillus brevis/enzimologia , Ácido gama-Aminobutírico/biossíntese , Fermentação/efeitos dos fármacos , Regulação Bacteriana da Expressão Gênica/efeitos dos fármacos , Genes Bacterianos , Loci Gênicos , Glutamato Descarboxilase/genética , Concentração de Íons de Hidrogênio , Isoenzimas/metabolismo , Levilactobacillus brevis/efeitos dos fármacos , Levilactobacillus brevis/genética , Levilactobacillus brevis/crescimento & desenvolvimento , Óperon/genética , Filogenia , Deleção de Sequência , Especificidade por Substrato/efeitos dos fármacos , Temperatura , Fatores de Tempo
8.
Int J Mol Sci ; 19(1)2018 Jan 04.
Artigo em Inglês | MEDLINE | ID: mdl-29300336

RESUMO

Lactic acid bacteria were isolated from fish and evaluated for their γ-aminobutyric acid (GABA)-producing abilities. Out of thirty-two isolates, Lactobacillus brevis RK03 showed the highest GABA production ability. The effects of various fermentation parameters including initial glutamic acid level, culture temperature, initial pH, and incubation time on GABA production were investigated via a singleparameter optimization strategy. For industrial large-scale production, a low-cost GABA producing medium (GM) broth was developed for fermentation with L. brevis RK03. We found that an optimized GM broth recipe of 1% glucose; 2.5% yeast extract; 2 ppm each of CaCO3, MnSO4, and Tween 80; and 10 µM pyridoxal phosphate (PLP) resulted in a maximum GABA yield of 62,523 mg/L after 88 h following the addition of 650 mM monosodium glutamate (MSG), for a conversion rate of 93.28%. Our data provide a practical approach for the highly efficient and economic production of GABA. In addition, L. brevis RK03 is highly resistant to gastric acid and bovine bile salt. Thus, the discovery of Lactobacillus strains with the ability to synthesize GABA may offer new opportunities in the design of improved health-promoting functional foods.


Assuntos
Técnicas de Cultura Celular por Lotes/métodos , Fermentação , Levilactobacillus brevis/metabolismo , Probióticos/metabolismo , Ácido gama-Aminobutírico/biossíntese , Ácidos/toxicidade , Animais , Antibacterianos/farmacologia , Carbono/farmacologia , Fermentação/efeitos dos fármacos , Peixes/microbiologia , Concentração de Íons de Hidrogênio , Mucosa Intestinal/metabolismo , Levilactobacillus brevis/efeitos dos fármacos , Levilactobacillus brevis/isolamento & purificação , Viabilidade Microbiana/efeitos dos fármacos , Nitrogênio/farmacologia , Temperatura , Água
9.
J Trace Elem Med Biol ; 40: 1-9, 2017 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-28159215

RESUMO

The present study was designed to isolate a highly selenium-tolerant lactobacillus strain from an Iranian traditional dairy product named as Spar. Different criteria such as tolerance to the low pH, simulated gastric juice (SGJ), simulated intestinal juice (SIJ) and bile salts tolerance as well as Caco-2 cell adhesion assay were examined to evaluate the probiotic potentials of the selected isolate. Furthermore, the antioxidant properties of the isolate cultivated in medium containing and free of SeO32- ions were evaluated using DPPH scavenging and reducing power assays. The isolate was identified using conventional identification and 16S rDNA gene sequencing methods as Lactobacillus brevis LSe. The obtained results showed that the isolate was able to tolerate high concentration of sodium selenite (3.16mM). By decreasing the pH of the SGJ from 6 to 3, the survival percent of L. brevis LSe was not significantly changed over the time (p>0.05). In addition, the survival percent of the isolate in the SIJ (pH 6 and pH 8) was not statistically altered after 3h, 6h and 24h of incubation (p>0.05). In the presence of bile salts (0.3% and 0.6%) the survival rate of L. brevis LSe was not significantly decreased (p>0.05).L. brevis LSe also demonstrated the satisfactory ability to adhere to Caco-2 cells which were similar to that of the reference strain L. plantarum. The obtained results of antioxidant evaluation showed that L. brevis LSe containing elemental Se exhibited significantly higher radical scavenging ability (36.5±1.31%) and reducing power (OD700, 0.14) than L. brevis LSe cultured in selenite-free medium (p<0.05). To sum up, further investigations should be conducted to merit the probable potential health benefit of Se-enriched L. brevis LSe and its application as Se-containing supplements or fermented foods.


Assuntos
Antioxidantes/metabolismo , Laticínios/microbiologia , Levilactobacillus brevis/isolamento & purificação , Levilactobacillus brevis/metabolismo , Probióticos , Selênio/metabolismo , Células CACO-2 , Adesão Celular/efeitos dos fármacos , Humanos , Irã (Geográfico) , Levilactobacillus brevis/química , Levilactobacillus brevis/efeitos dos fármacos , Selênio/farmacologia
10.
J Microbiol Biotechnol ; 26(7): 1182-9, 2016 Jul 28.
Artigo em Inglês | MEDLINE | ID: mdl-27056470

RESUMO

Lactobacillus brevis ATCC 14869 exhibited a carbon catabolite de-repressed (CCR) phenotype which has ability to consume fermentable sugar simultaneously with glucose. To evaluate this unusual phenotype under harsh conditions during fermentation, the effect of lactic acid and hydrogen ion concentrations on L. brevis ATCC 14869 were examined. Kinetic equations describing the relationship between specific cell growth rate and lactic acid or hydrogen ion concentration has been reduced. The change of substrate utilization and product formation according to lactic acid and hydrogen ion concentration in the media were quantitatively described. Moreover; utilization of other compounds were also observed along with hydrogen ion and lactic acid concentration simultaneously. It has been found that substrate preference changes significantly regarding to utilization of compounds in media. That could result into formation of two-carbon products. In particular, acetic acid present in the media as sodium acetate were consumed by L. brevis ATCC 14869 under extreme pH of both acid and alkaline conditions.


Assuntos
Carbono/metabolismo , Fermentação , Glucose/metabolismo , Ácido Láctico/metabolismo , Levilactobacillus brevis/metabolismo , Xilose/metabolismo , Concentração de Íons de Hidrogênio , Cinética , Ácido Láctico/farmacologia , Levilactobacillus brevis/efeitos dos fármacos , Levilactobacillus brevis/crescimento & desenvolvimento
11.
ACS Nano ; 9(7): 7215-25, 2015 Jul 28.
Artigo em Inglês | MEDLINE | ID: mdl-26168153

RESUMO

Copper formulations have been used for decades for antimicrobial and antifouling applications. With the development of nanoformulations of copper that are more effective than their ionic and microsized analogues, a key regulatory question is whether these materials should be treated as new or existing materials. To address this issue, here we compare the magnitude and mechanisms of toxicity of a series of Cu species (at concentration ranging from 2 to 250 µg/mL), including nano Cu, nano CuO, nano Cu(OH)2 (CuPro and Kocide), micro Cu, micro CuO, ionic Cu(2+) (CuCl2 and CuSO4) in two species of bacteria (Escherichia coli and Lactobacillus brevis). The primary size of the particles studied ranged from 10 nm to 10 µm. Our results reveal that Cu and CuO nanoparticles (NPs) are more toxic than their microsized counterparts at the same Cu concentration, with toxicities approaching those of the ionic Cu species. Strikingly, these NPs showed distinct differences in their mode of toxicity when compared to the ionic and microsized Cu, highlighting the unique toxicity properties of materials at the nanoscale. In vitro DNA damage assays reveal that both nano Cu and microsized Cu are capable of causing complete degradation of plasmid DNA, but electron tomography results show that only nanoformulations of Cu are internalized as intact intracellular particles. These studies suggest that nano Cu at the concentration of 50 µg/mL may have unique genotoxicity in bacteria compared to ionic and microsized Cu.


Assuntos
Anti-Infecciosos/toxicidade , Cobre/toxicidade , Escherichia coli/efeitos dos fármacos , Levilactobacillus brevis/efeitos dos fármacos , Nanopartículas Metálicas/toxicidade , Anti-Infecciosos/química , Cobre/química , Nanopartículas Metálicas/química
12.
Biomed Res Int ; 2015: 315819, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26101771

RESUMO

The suitable properties of potential probiotic lactic acid bacteria (LAB) strains (preselected among 153 strains on the basis of their potential technological properties) isolated from traditional Çubuk pickles were examined in vitro. For this purpose, these strains (21 Lactobacillus plantarum, 11 Pediococcus ethanolidurans, and 7 Lactobacillus brevis) were tested for the ability to survive at pH 2.5, resistance to bile salts, viability in the presence of pepsin-pancreatin, ability to deconjugate bile salts, cholesterol assimilation, and surface hydrophobicity properties. Most of the properties tested could be assumed to be strain-dependent. However, L. plantarum and L. brevis species were found to possess desirable probiotic properties to a greater extent compared to P. ethanolidurans. In contrast to P. ethanolidurans strains, the tested L. plantarum and L. brevis strains exhibited bile salt tolerance, albeit to different extent. All tested strains showed less resistance to intestinal conditions than gastric juice environment. Based on the survival under gastrointestinal conditions, 22 of the 39 strains were selected for further characterization. The eight strains having the highest cholesterol assimilation and surface hydrophobicity ratios could be taken as promising probiotic candidates for further in vivo studies, because of the strongest variations found among the tested strains with regard to these properties.


Assuntos
Microbiologia de Alimentos , Viabilidade Microbiana/efeitos dos fármacos , Probióticos/metabolismo , Ácidos e Sais Biliares/toxicidade , Suco Gástrico/efeitos dos fármacos , Concentração de Íons de Hidrogênio , Ácido Láctico/metabolismo , Levilactobacillus brevis/efeitos dos fármacos , Levilactobacillus brevis/crescimento & desenvolvimento , Lactobacillus plantarum/efeitos dos fármacos , Pediococcus/efeitos dos fármacos , Pediococcus/crescimento & desenvolvimento , Pepsina A/metabolismo , Probióticos/isolamento & purificação
13.
Food Microbiol ; 46: 553-563, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25475328

RESUMO

The main bittering component in beer, hop iso-α-acids, have been characterised as weak acids, which act as ionophores impairing microbial cells' function under acidic conditions as present in beer. Besides medium pH, divalent cations play a central role regarding the efficacy of the antimicrobial effect. The iso-α-acids' non-bitter derivatives humulinic acids can be found in isomerised hop extracts and can be generated during hop storage. Therefore, they have been under investigation concerning their influence on beer sensory properties. This study sketches the molecular mechanism behind iso-α-acids' antimicrobial activity in Lactobacillus (L.) brevis regarding their ionophore activity versus the dependence of the inhibitory potential on manganese binding, and suggests humulinic acids as novel tasteless food preservatives. We designed and synthesised chemically modified iso-α-acids to enhance the basic understanding of the molecular mechanism of antimicrobial iso-α-acids. It could be observed that a manganese-binding dependent transmembrane redox reaction (oxidative stress) plays a crucial role in inhibition. Privation of an acidic hydroxyl group neither erased ionophore activity, nor did it entirely abolish antimicrobial activity. Humulinic acids proved to be highly inhibitory, even outperforming iso-α-acids.


Assuntos
Antibacterianos/química , Antibacterianos/farmacologia , Ciclopentanos/química , Ciclopentanos/farmacologia , Humulus/química , Levilactobacillus brevis/efeitos dos fármacos , Cerveja/análise , Cerveja/microbiologia , Humulus/microbiologia , Isomerismo , Levilactobacillus brevis/crescimento & desenvolvimento , Estrutura Molecular
14.
Biosci Biotechnol Biochem ; 78(12): 2120-7, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25130618

RESUMO

Some Lactobacillus brevis strains were found to aggregate upon the addition of xylan after screening for lactic acid bacteria that interact with plant materials. The S-layer proteins of cell surface varied among the strains. The strains that displayed xylan-mediated aggregation retained its ability even after the removal of S-layer proteins. L. brevis had negative zeta potentials. A correlation between the strength of aggregation and zeta potential was not observed. However, partial removal of S-layer proteins resulted in decreases in the electric potential and aggregation ability of some strains. Therefore, xylan-mediated aggregation of L. brevis was considered to be caused by an electrostatic effect between the cells and xylan. L. brevis also aggregated in the presence of mucin, and the strengths of aggregation among the strains were similar to that induced by xylan. Thus, xylan- and mucin-mediated L. brevis aggregation was supposed to be caused by a similar mechanism.


Assuntos
Levilactobacillus brevis/efeitos dos fármacos , Mucinas/farmacologia , Xilanos/farmacologia , Meios de Cultura/química , Levilactobacillus brevis/química , Levilactobacillus brevis/crescimento & desenvolvimento , Cloreto de Lítio/farmacologia , Glicoproteínas de Membrana/química , Glicoproteínas de Membrana/isolamento & purificação , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Eletricidade Estática , Propriedades de Superfície
15.
Artigo em Inglês | MEDLINE | ID: mdl-25010287

RESUMO

Humans can be exposed to N-nitroso compounds (NOCs) due to many environmental sources, as well as endogenous formation. The main nitrosamine found in food products and also synthesised in vivo by intestinal microbiota is N-nitrosodimethylamine (NDMA). It can cause cancer of the stomach, kidney and colon. The effect of four probiotic Lactobacillus strains on NDMA was studied under different culture conditions (24 h in MRS, 168 h in modified MRS N, and 168 h in phosphate buffer). HPLC and GC-TEA methods were used for NDMA determination in supernatants. The influence of lactic acid bacteria on NDMA genotoxicity was investigated by means of the comet assay. Additionally, the effect of NDMA (2-100 µg ml⁻¹) on the growth and survival of the probiotic strains was studied. The results indicate that the bacteria decreased NDMA concentration by up to 50%, depending on the culture conditions, time of incubation, NDMA concentration, pH and bacterial strain. Lb. brevis 0945 lowered the concentration and genotoxicity of NDMA most effectively by up to 50%. This could be due to either adsorption or metabolism. The growth and survival of the bacteria was not affected by any of the tested NDMA concentrations.


Assuntos
Carcinógenos Ambientais/metabolismo , Dimetilnitrosamina/metabolismo , Lactobacillus/metabolismo , Mutagênicos/metabolismo , Probióticos/metabolismo , Adsorção , Carcinógenos Ambientais/análise , Carcinógenos Ambientais/química , Carcinógenos Ambientais/toxicidade , Ensaio Cometa , Dano ao DNA , Dimetilnitrosamina/análise , Dimetilnitrosamina/química , Dimetilnitrosamina/toxicidade , Contaminação de Alimentos , Células HL-60 , Humanos , Concentração de Íons de Hidrogênio , Inativação Metabólica , Cinética , Lactobacillus/efeitos dos fármacos , Lactobacillus/crescimento & desenvolvimento , Levilactobacillus brevis/efeitos dos fármacos , Levilactobacillus brevis/crescimento & desenvolvimento , Levilactobacillus brevis/metabolismo , Lacticaseibacillus casei/efeitos dos fármacos , Lacticaseibacillus casei/crescimento & desenvolvimento , Lacticaseibacillus casei/metabolismo , Lacticaseibacillus rhamnosus/efeitos dos fármacos , Lacticaseibacillus rhamnosus/crescimento & desenvolvimento , Lacticaseibacillus rhamnosus/metabolismo , Viabilidade Microbiana/efeitos dos fármacos , Mutagênicos/análise , Mutagênicos/química , Mutagênicos/toxicidade , Especificidade da Espécie
16.
Mol Microbiol ; 92(4): 853-71, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24684290

RESUMO

In this study we uncover two genes in Lactobacillus brevis ATCC 367, tstT and tstR, encoding for a rhodanese and a transcriptional regulator involved in cyanide detoxification. TstT (LVIS_0852) belongs to a new class of thiosulphate:cyanide sulphurtransferases. We found that TstR (LVIS_0853) modulates both the expression and the activity of the downstream-encoded tstT. The TstR binding site was identified at -1 to +33, from tstR transcriptional start site. EMSA revealed that sulphite, a product of the reaction catalysed by TstT, improved the interaction between TstR:P(tstR), while Fe(III) disrupted this interaction. Site-directed mutagenesis in TstR identified M64 as a key residue in sulphite recognition, while residues H136-H139-C167-M171 formed a pocket for ferric iron co-ordination. In addition to its role as a transcriptional repressor, TstR is also involved in regulating the thiosulphate:cyanide sulphurtransferase activity of TstT. A threefold increase in TstT activity was observed in the presence of TstR, which was enhanced by the addition of Fe(III). Overexpression of the tstRT operon was found to increase the cyanide tolerance of L. brevis and Escherichia coli. The protein-protein interaction between TstR and TstT described herein represents a novel mechanism for regulation of enzymatic activity by a transcriptional regulator.


Assuntos
Cianetos/metabolismo , Regulação Bacteriana da Expressão Gênica , Levilactobacillus brevis/metabolismo , Proteínas Repressoras/metabolismo , Tiossulfato Sulfurtransferase/metabolismo , Sítios de Ligação , Biotransformação , Clonagem Molecular , Tolerância a Medicamentos , Ensaio de Desvio de Mobilidade Eletroforética , Escherichia coli/efeitos dos fármacos , Escherichia coli/genética , Compostos Férricos/metabolismo , Expressão Gênica , Levilactobacillus brevis/efeitos dos fármacos , Mutagênese Sítio-Dirigida , Regiões Promotoras Genéticas , Ligação Proteica , Proteínas Repressoras/genética , Sulfitos/metabolismo , Tiossulfato Sulfurtransferase/genética , Sítio de Iniciação de Transcrição , Transcrição Gênica
17.
Can J Microbiol ; 60(4): 183-91, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24693976

RESUMO

Bile tolerance is a fundamental ability of probiotic bacteria. We examined this property in 56 Lactobacillus brevis strains isolated from Japanese pickles and also evaluated cellular fatty acid composition and cell-bound exopolysaccharide (EPS-b) production. The bile tolerance of these strains was significantly lower in modified de Man - Rogosa - Sharpe (MRS) medium (without Tween 80 or sodium acetate) than in standard MRS medium. Aggregating strains showed significantly higher bile tolerance than nonaggregating strains in MRS medium, but there was no significant difference in the modified MRS media. The relative octadecenoic acid (C18:1) content of the 3 most tolerant aggregating and nonaggregating strains was significantly higher when bile was added to MRS. In MRS without Tween 80, the relative C18:1 content was only marginally affected by addition of bile. In MRS without sodium acetate, only the 3 most tolerant nonaggregating strains increased their relative C18:1 content in the presence of bile. Meanwhile, culture in MRS without sodium acetate reduced EPS-b production in aggregating strains. In conclusion, both EPS-b and cellular fatty acid composition play important roles in bile tolerance of pickle-derived L. brevis.


Assuntos
Bile/metabolismo , Cucumis sativus/microbiologia , Ácidos Graxos/análise , Levilactobacillus brevis/química , Polissacarídeos Bacterianos/isolamento & purificação , Meios de Cultura/química , Ácidos Graxos/isolamento & purificação , Fezes/microbiologia , Fermentação , Microbiologia de Alimentos , Humanos , Japão , Levilactobacillus brevis/efeitos dos fármacos , Levilactobacillus brevis/isolamento & purificação , Polissacarídeos Bacterianos/química , Probióticos
18.
PLoS One ; 9(3): e90866, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24598940

RESUMO

Five novel Lactobacillus brevis strains were isolated from naturally fermented Aloe vera leaf flesh. Each strain was identified by Random Amplified Polymorphic DNA (RAPD) analysis and 16S rRNA sequence comparison. These strains were highly tolerant to acid, surviving in pH2.5 for up to 4 hours, and resistant to 5% bile salts at 37°C for 18 hours. Due to its tolerance to acid and bile salts, one strain passed through the gastric barrier and colonised the intestine after oral administration. All five strains inhibited the growth of many harmful enteropathogens without restraining most of normal commensals in the gut and hence named POAL (Probiotics Originating from Aloe Leaf) strains. Additionally, each strain exhibited discriminative resistance to a wide range of antibiotics. The L. brevis POAL strains, moreover, expressed high levels of the glutamate decarboxylase (GAD) gene which produces a beneficial neurotransmitter, γ-aminobutyric acid (GABA). These characteristics in all suggest that the novel L. brevis strains should be considered as potential food additives and resources for pharmaceutical research.


Assuntos
Aloe/microbiologia , Duodeno/microbiologia , Fermentação , Microbiologia de Alimentos , Levilactobacillus brevis/isolamento & purificação , Viabilidade Microbiana , Estômago/microbiologia , Animais , Antibacterianos/farmacologia , Sequência de Bases , Ácidos e Sais Biliares/farmacologia , Fermentação/efeitos dos fármacos , Glutamato Descarboxilase/genética , Glutamato Descarboxilase/metabolismo , Concentração de Íons de Hidrogênio , Levilactobacillus brevis/efeitos dos fármacos , Camundongos , Testes de Sensibilidade Microbiana , Viabilidade Microbiana/efeitos dos fármacos , Dados de Sequência Molecular , Filogenia , Folhas de Planta/microbiologia , Probióticos/farmacologia , RNA Ribossômico 16S/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa
19.
Can J Microbiol ; 60(3): 139-45, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24588387

RESUMO

Cell-bound exopolysaccharide (EPS) of the aggregable strain Lactobacillus brevis KB290 isolated from traditional Japanese pickles has been reported to protect against the effects of bile. However, there are no reports of bile tolerance mechanisms for other L. brevis strains that have aggregability. To elucidate the mechanism of bile tolerance of L. brevis KB290, we found 8 aggregable L. brevis strains out of 121 L. brevis strains isolated from traditional Japanese fermented pickles. We estimated their growth in artificial digestive juice and the amount of cell-bound EPS. We found 3 types of aggregation for these strains: filiform (<1 mm), medium floc (1-5 mm), or large floc (>5 mm). There was no significant difference in growth between nonaggregable and aggregable strains in the artificial digestive juice. The large floc strains selected from the aggregation strains showed significantly higher growth in the artificial digestive juice than nonaggregable strains. In medium and large floc strains, cell-bound EPS, mainly consisting of glucose, N-acetylglucosamine, and N-acetylmannosamine, were observed. The amount of EPS and each strain's growth index showed a positive correlation. We conclude that aggregable L. brevis strains were also protected by cell-bound EPS.


Assuntos
Ácidos e Sais Biliares/metabolismo , Suco Gástrico/metabolismo , Secreções Intestinais/metabolismo , Levilactobacillus brevis/crescimento & desenvolvimento , Polissacarídeos Bacterianos/metabolismo , Verduras/microbiologia , Acetilglucosamina/metabolismo , Bile/metabolismo , Ácidos e Sais Biliares/farmacologia , Fermentação , Glucose/metabolismo , Hexosaminas/metabolismo , Humanos , Levilactobacillus brevis/efeitos dos fármacos
20.
Can J Microbiol ; 59(8): 549-55, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23898998

RESUMO

We examined the survivability of Lactobacillus brevis KB290 and derivative strain KB392 in artificial digestive juices and bile salts. The strains have similar membrane fatty acids but different amounts of cell-bound exopolysaccharides (EPS). In artificial digestive juices, KB290 showed significantly higher survivability than KB392, and homogenization, which reduced the amount of EPS in KB290 but not in KB392, reduced the survivability only of KB290. In bile salts, KB290 showed significantly higher survivability than KB392, and cell-bound EPS extraction with EDTA reduced the survivability of only KB290. Transmission electron microscopy showed there to be a greater concentration of cell-bound EPS in KB290 than in either KB392 or EDTA-treated or homogenized KB290. We conclude that KB290's cell-bound EPS (which high performance liquid chromatography showed to be made up of glucose and N-acetylglucosamine) played an important role in bile salt tolerance.


Assuntos
Levilactobacillus brevis/fisiologia , Lipídeos de Membrana/química , Monossacarídeos/análise , Polissacarídeos Bacterianos/química , Polissacarídeos Bacterianos/metabolismo , Ácidos e Sais Biliares/farmacologia , Quelantes/farmacologia , Ácido Edético/farmacologia , Suco Gástrico/microbiologia , Levilactobacillus brevis/química , Levilactobacillus brevis/efeitos dos fármacos , Levilactobacillus brevis/metabolismo , Viabilidade Microbiana/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA